Skip to main content
TipRanks
Go Ultimate75% OFF

Bioline Rx (BLRX) Q4 2023 Earnings Report

3 Followers

IL:BLRX Q4 2023 EPS Results

Actual EPS
-ILA 4.13
Consensus EPS
-ILA 4.76
Beat/Miss
Beat by +ILA 0.63
One Year Ago EPS
-ILA 1.90

IL:BLRX Q4 2023 Revenue Results

Actual Revenue
ILA 1.83B
Expected Revenue
ILA 47.62M
Beat/Miss
Beat by +ILA 1.79B
YoY Revenue Growth
―

Earnings Announcement Details

Quarter
Q4 2023
Date
03/26/2024
Time
Before Open
Conference Call
Tuesday, March 26, 2024
IL:BLRX Upcoming Earnings

Bioline Rx's next earnings date is estimated for November 18, 2026, based on past reporting schedules.

Q4 2023 Earnings Call Audio

No earnings call audio is available for this earnings event.

Q4 2023 Earnings Slide Deck

No slide deck is available for this earnings event.

Q4 2023 Earnings Call Summary

No earnings call summary is available for this earnings event.

IL:BLRX Earnings History

IL:BLRX earnings history
Report DateFiscal QuarterForecast / EPSLast Year's EPSEPS YoY ChangePress Release
Nov 18, 20262026 (Q3)-0.32-0――
Aug 31, 20262026 (Q2)0.000.000―
May 27, 20262026 (Q1)-0.630.000―
Mar 23, 20262025 (Q4)-0.320.00-0.95100.00% (+0.95)
Nov 24, 20252025 (Q3)-0.320.000―
Aug 14, 20252025 (Q2)-0.320.000―
May 27, 20252025 (Q1)―-0―
Mar 31, 20252024 (Q4)-0.630.000―
Nov 25, 20242024 (Q3)-0.950.00-6.35100.00% (+6.35)
Aug 15, 20242024 (Q2)―0.00-6.35100.00% (+6.35)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat Missed